Iodine123FPCTQualityChecker

Iodine-123 FP-CIT

radiopharmaceuticals QC URS & FS input.csv output.json radiochemical purity radionuclidic purity PET
Open selection

Utility description: Iodine-123 FP-CIT

Iodine-123 FP-CIT Quality Checker — Ioflupane I-123 (DaTscan®)

ℹ️  Utility checks critical parameters of the radiopharmaceutical for dopamine transporter imaging:
    • Radiochemical purity (≥95%)
    • Free Iodine-123 impurity (≤5%)
    • Radionuclidic impurity Iodine-124 (≤0.3%) — CRITICAL!
    • Radionuclidic impurity Iodine-125 (≤0.1%)
    • Specific activity (≥100 GBq/μmol)
    • pH, endotoxins, sterility, residual ethanol

⚠️  CRITICAL: I-124 impurity >0.3% is unacceptable! I-124 emits positrons and high-energy gamma rays, significantly increasing patient dose and degrading image quality (noise).
    Free iodine accumulates in the thyroid and stomach, creating artifacts.

Usage:
  Iodine123FPCTQualityChecker.exe                            → demo mode (console output)
  Iodine123FPCTQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore

Example (sterility: 0=sterile, 1=contaminated, appearance: 0=normal):
  I123-FPCT-2026-001,98.5,1.0,0.1,0.05,150.0,7.0,40.0,0,5.0,0

— WHY IS THIS NEEDED?
Ioflupane I-123 (DaTscan®) is used for diagnosing Parkinson's disease and other parkinsonian syndromes.
• I-123 (T½=13.2 hours) binds to presynaptic dopamine transporters (DAT) in the striatum.
• Allows differentiation of neurodegenerative parkinsonism (reduced uptake) from essential tremor (normal uptake).

⚠️  CRITICAL:
• Radiochemical purity ≥95% — ensures specific binding to DAT.
• Free Iodine-123 ≤5% — requires thyroid blocking with potassium iodide prior to administration if impurity is high.
• I-124 impurity ≤0.3% — I-124 (T½=4.18 days) has high positron yield, increasing dose and creating noise.
• Specific activity ≥100 GBq/μmol — necessary to prevent cold ligand from competing for receptors, which would weaken the signal.
• pH 6.0–8.0 — physiological compatibility.
• Ethanol ≤10% — solvent for the hydrophobic ligand.

Key features:
• Strict control of radionuclidic impurities (I-124/I-125) characteristic of cyclotron-produced I-123.
• Specific activity control to prevent receptor saturation.
• Appearance check (clarity/color) as the product is light-sensitive.

Critical parameters:
• Radiochemical purity: ≥95.0%
• Free Iodine-123: ≤5.0%
• I-124 impurity: ≤0.3%
• I-125 impurity: ≤0.1%
• Specific activity: ≥100 GBq/μmol
• pH: 6.0–8.0
• Endotoxins: ≤175 EU/vial
• Sterility: no microbial growth
• Ethanol: ≤10.0%

💡 Usage tips:
1. RCP is controlled by HPLC or TLC.
2. Radionuclidic purity is determined by gamma spectrometry (I-124 peaks: 602 keV, 1691 keV; I-123: 159 keV).
3. Patients must be prescribed perchlorate or potassium iodide 1 hour before injection to block the thyroid.
4. Protect the product from light (photosensitive).

⚠️ Note: Production of I-123 is often accompanied by the formation of I-124 via the (p,2n) reaction on tellurium-124 if proton energy is too high. Control of I-124 is a marker of cyclotron irradiation quality.

input.csv

BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore
I123-FPCT-2026-001,98.5,1.0,0.1,0.05,150.0,7.0,40.0,0,5.0,0
I123-FPCT-2026-002,94.0,4.0,0.5,0.08,120.0,7.2,50.0,0,6.0,0

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of Iodine123FPCTQualityChecker for Iodine-123 FP-CIT.

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.
  • ℹ️ Utility checks critical parameters of the radiopharmaceutical for dopamine transporter imaging:
  • • Radiochemical purity (≥95%)
  • • Free Iodine-123 impurity (≤5%)
  • • Radionuclidic impurity Iodine-124 (≤0.3%) — CRITICAL!
  • • Radionuclidic impurity Iodine-125 (≤0.1%)
  • • Specific activity (≥100 GBq/μmol)
  • • pH, endotoxins, sterility, residual ethanol
  • ⚠️ CRITICAL: I-124 impurity >0.3% is unacceptable! I-124 emits positrons and high-energy gamma rays, significantly increasing patient dose and degrading image quality (noise).
  • Free iodine accumulates in the thyroid and stomach, creating artifacts.
  • BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore
  • Example (sterility: 0=sterile, 1=contaminated, appearance: 0=normal):
  • ⚠️ CRITICAL:
  • • Radiochemical purity ≥95% — ensures specific binding to DAT.
  • • Free Iodine-123 ≤5% — requires thyroid blocking with potassium iodide prior to administration if impurity is high.

URS — User Requirements Specification

IDRequirementCriticalityAcceptance criterion
URS-001The utility shall accept an input.csv file with the exact headers defined in the data contract.HighThe file is processed without manual header editing.
URS-002The utility shall perform deterministic QC evaluation for Iodine-123 FP-CIT using input values, approved limits and domain rules.HighEach input row receives a PASS / WARNING / FAIL status.
URS-003The utility shall validate mandatory fields, data types, numeric ranges, units and pharmaceutical/radiochemical plausibility.HighSchema and conversion errors are explicitly reported.
URS-004The utility shall identify critical deviations related to radionuclidic purity, radiochemical purity, free radionuclide, impurities, pH, endotoxins and sterility when such fields are present.HighA critical deviation causes FAIL or a separate critical finding.
URS-005The utility shall generate output.json with machine-readable results, source values, warnings and failures.HighJSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006The utility shall not use machine learning to decide conformance.MediumThe result is based on explicit rules, thresholds and input values.
URS-007The utility shall preserve traceability between batch number, input values, applied rules and final status.HighThe output contains the batch identifier and the list of checked parameters.
URS-008The documentation shall support IQ/OQ preparation and inspection discussion with FDA/EMA/Roszdravnadzor or local regulators.MediumURS & FS, input.csv/output.json contract and test scenarios are supplied with the utility.

input.csv contract

#FieldTypeSamplePurpose
1BatchNumberstringI123-FPCT-2026-001Batch or lot identifier used for traceability.
2RadiochemicalPurityPercentstring98.5Radiochemical purity; confirms the labelled chemical form and binding quality.
3FreeIodine123Percentdecimal1.0Free radionuclide / unbound species; important for non-target uptake and toxicity.
4RadionuclidicPurityI124Percentstring0.1Radionuclidic purity; a critical radiation-safety and impurity parameter.
5RadionuclidicPurityI125Percentstring0.05Radionuclidic purity; a critical radiation-safety and impurity parameter.
6SpecificActivityGBqPerUmoldecimal150.0Radioactivity value used for release, decay or dose-related assessment.
7pHdecimal7.0Solution pH; relevant for stability, compatibility and administration.
8EndotoxinsEUdecimal40.0Bacterial endotoxins; critical for parenteral administration.
9SterilityTestflag / boolean0Sterility result; critical release parameter.
10EthanolPercentdecimal5.0Controlled input parameter used by the deterministic QC rules.
11AppearanceScorestring0Visual appearance / clarity parameter.
BatchNumber,RadiochemicalPurityPercent,FreeIodine123Percent,RadionuclidicPurityI124Percent,RadionuclidicPurityI125Percent,SpecificActivityGBqPerUmol,pH,EndotoxinsEU,SterilityTest,EthanolPercent,AppearanceScore
I123-FPCT-2026-001,98.5,1.0,0.1,0.05,150.0,7.0,40.0,0,5.0,0
I123-FPCT-2026-002,94.0,4.0,0.5,0.08,120.0,7.2,50.0,0,6.0,0

FS — Functional Specification

IDFunctionImplementation
FS-001CSV importRead input.csv in UTF-8/CSV-compatible format and validate the header and expected columns.
FS-002Schema validationCheck mandatory fields and column count; report unknown or missing key fields.
FS-003Type conversionConvert numeric, flag and text values; invalid formats are recorded as row-level errors.
FS-004Domain rule engineApply domain rules for Iodine-123 FP-CIT, including critical limits from the utility description and approved specification.
FS-005Status aggregationProduce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-006JSON exportWrite output.json with detailed checks, source values, warnings, failures and critical findings.
FS-007Audit supportKeep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ preparation.
FS-008Integration contractSupport the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, the portal displays description and documentation.

Example output.json

{
  "utilityId": "iodine123-fpct-quality-checker",
  "api": "Iodine-123 FP-CIT",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "I123-FPCT-2026-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadiochemicalPurityPercent",
      "value": "98.5",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "FreeIodine123Percent",
      "value": "1.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityI124Percent",
      "value": "0.1",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "RadionuclidicPurityI125Percent",
      "value": "0.05",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "SpecificActivityGBqPerUmol",
      "value": "150.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "pH",
      "value": "7.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    },
    {
      "parameter": "EndotoxinsEU",
      "value": "40.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Rule-based check result"
    }
  ],
  "criticalFindings": []
}

OQ/PQ test scenarios

IDScenarioExpected result
OQ-001Valid sample rowPASS or acceptable WARNING according to the rules.
OQ-002Mandatory column missingSchema error or FAIL.
OQ-003Non-numeric value in numeric fieldType-conversion error.
OQ-004Critical parameter outside limitFAIL and critical finding.
PQ-001User real batch/lotReviewed result with input.csv and output.json retained.

QA/QC and change control

  • Do not rename columns without updating the validator and test set.
  • Retain input.csv, output.json, executable version and checksum.
  • Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
  • Critical radiopharmaceutical limits must be verified against the approved specification and local SOPs.

Included in packages

Endocrinology QC Suite

QC package for endocrinology: thyroid, pituitary/peptide hormones, corticosteroids, sex hormones and selected metabolic medicines.

Open

Neurology QC Suite

QC package for neurology and neuropsychiatry: antiepileptics, antiparkinsonian medicines, antidepressants, antipsychotics, analgesics and neurological diagnostic radiopharmaceuticals.

Open

PetRad3: expanded PET/SPECT and radiopharmaceutical QC package

A curated suite for PET/SPECT radiopharmaceuticals, generator and cyclotron radionuclides, labelled compounds, radiochemical purity, breakthrough, sterility and endotoxin control.

Open

Radiology QC Suite

QC package for radiology and diagnostic imaging: radiopharmaceuticals, PET/SPECT, contrast media, iodinated and gadolinium products, plus particle, sterility and endotoxin checks.

Open

RPH isotope family: radioiodine

I-123, I-124, I-125 and I-131 for diagnostics, therapy, labelling and purity control.

Open

RPH organ/system: brain and CNS

Brain perfusion, dopamine transporter, amyloid/tau, receptor imaging and neurological SPECT/PET.

Open

RPH organ/system: endocrine, thyroid and NET

Radioiodine, thyroid/parathyroid, somatostatin receptor, MIBG and neuroendocrine workflows.

Open

RPH use case: generators, isotope purity and starting radionuclides

Control of generator eluate, breakthrough, radionuclidic purity, isotope mix, carrier/free radionuclides and starting radionuclides before labeling.

Open

RPH workflow: generators and isotope purity

Generator eluate, breakthrough, radionuclidic purity, isotope mix and starting radionuclides.

Open

RPH workflow: imaging QC and quantitative interpretation

Acquisition, uptake, clearance, perfusion, transit, ejection fraction, segmentation and quantitative imaging.

Open

RPH workflow: product release QC

Assay, purity, sterility, endotoxins, pH, impurities, appearance and batch-release checks.

Open

RPH: combined radiopharmaceutical QC package

RPH combines PetRad, PetRad2 and PetRad3 into one umbrella package for PET/SPECT, therapeutic radionuclides, generators, labelled compounds, decay calculations, sterility, endotoxins and radiochemical/radionuclidic purity.

Open